Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions.
Metformin is proposed as adjuvant therapy in cancer treatment because of its ability to limit cancer incidence by negatively modulating the PI3K/AKT/mTOR pathway. In vitro, in addition to inhibiting cancer cell proliferation, metformin can also induce apoptosis. The molecular mechanism underlying th...
Main Authors: | Alessandra Silvestri, Francesco Palumbo, Ignazio Rasi, Daniela Posca, Theodora Pavlidou, Serena Paoluzi, Luisa Castagnoli, Giovanni Cesareni |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4546379?pdf=render |
Similar Items
-
Regulation of myoblast differentiation by metabolic perturbations induced by metformin.
by: Theodora Pavlidou, et al.
Published: (2017-01-01) -
Metformin Delays Satellite Cell Activation and Maintains Quiescence
by: Theodora Pavlidou, et al.
Published: (2019-01-01) -
Pyruvate: A key Nutrient in Hypersaline Environments?
by: Aharon Oren
Published: (2015-08-01) -
Ethyl Pyruvate Inhibits Retinal Pathogenic Neovascularization by Downregulating HMGB1 Expression
by: Yun Mi Lee, et al.
Published: (2013-01-01) -
Metformin protects skeletal muscle from cardiotoxin induced degeneration.
by: Francesca Langone, et al.
Published: (2014-01-01)